[Reporter¡¯s View] Can companies get EUAs as they promised?
By Lee, Tak-Sun | translator Alice Kang
22.01.12 06:53:08
°¡³ª´Ù¶ó
0
The Emergency Use Authorization (EUA) system was first introduced to Korea in March last year. AstraZeneca¡¯s COVID-19 vaccine manufactured in Italy, Moderna¡¯s COVID-19 vaccine manufactured by Samsung Biologics, Pfizer¡¯s oral COVID-19 treatment Paxlovid, and the COVID-19 injection Remdesivir for use in patients under 15 were approved using Korea's EUA system.
All of the drugs above were introduced to Korea through EUA before receiving marketing authorization through an official process. Among these, AstraZeneca¡¯s vaccine that was manufactured overseas and Samsung Biologics¡¯ Moderna vaccine are now officially approved in Korea.
As such, the EUA system had gained attenti
Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)